These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38230208)

  • 41. MicroRNA-135a regulates sodium-calcium exchanger gene expression and cardiac electrical activity.
    Duong E; Xiao J; Qi XY; Nattel S
    Heart Rhythm; 2017 May; 14(5):739-748. PubMed ID: 28188930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.
    Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F
    World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
    Ahmad A; Zhang W; Wu M; Tan S; Zhu T
    Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
    Leung CO; Deng W; Ye TM; Ngan HY; Tsao SW; Cheung AN; Pang RT; Yeung WS
    Carcinogenesis; 2014 Sep; 35(9):1931-40. PubMed ID: 24503442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
    Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
    Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways.
    Zhou Y; Feng X; Liu YL; Ye SC; Wang H; Tan WK; Tian T; Qiu YM; Luo HS
    PLoS One; 2013; 8(11):e81203. PubMed ID: 24312276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA CASC2 restrains high glucose-induced proliferation, inflammation and fibrosis in human glomerular mesangial cells through mediating miR-135a-5p/TIMP3 axis and JNK signaling.
    Zhu D; Wu X; Xue Q
    Diabetol Metab Syndr; 2021 Aug; 13(1):89. PubMed ID: 34446088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-135a Targets SMAD2 to Promote Osteosarcoma Proliferation and Migration.
    Chen Y; Cai B; Lian X; Xu J; Zhang T
    J Oncol; 2022; 2022():3037348. PubMed ID: 35466322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
    Cao Z; Qiu J; Yang G; Liu Y; Luo W; You L; Zheng L; Zhang T
    Cancer Biol Med; 2020 Aug; 17(3):569-582. PubMed ID: 32944391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1.
    Zhang T; Wang N
    Oncol Res; 2018 Sep; 26(8):1191-1200. PubMed ID: 29386087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-135a-5p affects adipogenic differentiation of human adipose-derived mesenchymal stem cellsby promoting the Hippo signaling pathway.
    Gao S; Yang D; Huang W; Wang T; Li W
    Int J Clin Exp Pathol; 2018; 11(3):1347-1355. PubMed ID: 31938230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo.
    Yang C; Zheng X; Ye K; Sun Y; Lu Y; Fan Q; Ge H
    Mol Ther Nucleic Acids; 2020 Mar; 19():841-852. PubMed ID: 31981861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.
    Zhang LY; Wang Y; Yang YR; Shao JJ; Liang B
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1979-1987. PubMed ID: 32141566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
    Kroiss A; Vincent S; Decaussin-Petrucci M; Meugnier E; Viallet J; Ruffion A; Chalmel F; Samarut J; Allioli N
    Oncogene; 2015 May; 34(22):2846-55. PubMed ID: 25065599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-135a-5p and miR-124-3p Inhibit Malignancy of Glioblastoma by Downregulation of Syndecan Binding Protein.
    Lin J; Wen X; Zhang X; Sun X; Yunzhi L; Peng R; Zhu M; Wang M; Zhang Y; Luo W; Luo G; Zhang Y
    J Biomed Nanotechnol; 2018 Jul; 14(7):1317-1329. PubMed ID: 29944105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9.
    Zhang Y; Zhang Z; Yi Y; Wang Y; Fu J
    Onco Targets Ther; 2020; 13():5165-5176. PubMed ID: 32606737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.
    Holleman A; Chung I; Olsen RR; Kwak B; Mizokami A; Saijo N; Parissenti A; Duan Z; Voest EE; Zetter BR
    Oncogene; 2011 Oct; 30(43):4386-98. PubMed ID: 21552288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.